001     290048
005     20250508145209.0
024 7 _ |a 10.1007/s11553-024-01114-2
|2 doi
024 7 _ |a 1861-6755
|2 ISSN
024 7 _ |a 1861-6763
|2 ISSN
037 _ _ |a DKFZ-2024-00953
082 _ _ |a 360
100 1 _ |a Ihrig, Andreas
|0 0000-0002-8497-9193
|b 0
245 _ _ |a Psychosocial cancer counseling centers in Germany. Developments since the start of regular funding. [Psychosoziale Krebsberatungsstellen in Deutschland. Entwicklungen seit Beginn derRegelfinanzierung].
260 _ _ |a Heidelberg
|c 2025
|b Springer
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1746708703_31
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a Volume 20, pages 156–161, (2025)
536 _ _ |a 313 - Krebsrisikofaktoren und Prävention (POF4-313)
|0 G:(DE-HGF)POF4-313
|c POF4-313
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, Journals: inrepo02.dkfz.de
700 1 _ |a Akkus, Fatma Dilek
|b 1
700 1 _ |a Bruns, Gudrun
|b 2
700 1 _ |a Besseler, Markus
|b 3
700 1 _ |a Knurr, Alexander
|0 P:(DE-He78)d86248f91d13930d4a6ee02207362576
|b 4
|u dkfz
700 1 _ |a Friederich, Hans-Christoph
|0 0000-0003-4344-8959
|b 5
700 1 _ |a Bugaj, Till Johannes
|0 0000-0001-8287-2635
|b 6
773 _ _ |a 10.1007/s11553-024-01114-2
|0 PERI:(DE-600)2211781-7
|p 156–161
|t Prävention und Gesundheitsförderung
|v 20
|y 2025
|x 1861-6755
856 4 _ |u https://inrepo02.dkfz.de/record/290048/files/s11553-024-01114-2.pdf
|y Restricted
856 4 _ |u https://inrepo02.dkfz.de/record/290048/files/s11553-024-01114-2.pdf?subformat=pdfa
|x pdfa
|y Restricted
909 C O |p VDB
|o oai:inrepo02.dkfz.de:290048
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 4
|6 P:(DE-He78)d86248f91d13930d4a6ee02207362576
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-313
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Krebsrisikofaktoren und Prävention
|x 0
914 1 _ |y 2024
915 _ _ |a DEAL Springer
|0 StatID:(DE-HGF)3002
|2 StatID
|d 2023-10-25
|w ger
915 _ _ |a DEAL Springer
|0 StatID:(DE-HGF)3002
|2 StatID
|d 2023-10-25
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-10-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-10-25
915 _ _ |a WoS
|0 StatID:(DE-HGF)0112
|2 StatID
|b Emerging Sources Citation Index
|d 2023-10-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-10-25
920 1 _ |0 I:(DE-He78)M130-20160331
|k M130
|l Clinical Trial Office
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)M130-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21